Literature DB >> 8006254

Detection of coronary artery disease by digital stress echocardiography: comparison of exercise, transesophageal atrial pacing and dipyridamole echocardiography.

V Marangelli1, S Iliceto, G Piccinni, G De Martino, L Sorgente, P Rizzon.   

Abstract

OBJECTIVES: This study assessed and compared the diagnostic potential of exercise, transesophageal atrial pacing and dipyridamole stress echocardiography in a clinical setting.
BACKGROUND: Although they have been widely studied, no data exist with regard to comparisons of these procedures in a head-to-head study in different clinical settings.
METHODS: One hundred four consecutive patients with suspected coronary artery disease undergoing coronary angiography and with no previous myocardial infarction or rest left ventricular wall motion abnormalities underwent digital posttreadmill, transesophageal atrial pacing and dipyridamole echocardiography.
RESULTS: Feasibility of digital exercise echocardiography was 84%; 8 of 88 remaining patients had a nondiagnostic exercise echocardiographic test (inadequate exercise or imaging). In 80 patients with feasible and diagnostic digital exercise echocardiography, sensitivity, specificity and accuracy were, respectively, 89%, 91% and 90%. Eighty of the 104 patients underwent transesophageal atrial pacing and dipyridamole echocardiography. Feasibility of the alternative stress procedures was 77% for transesophageal atrial pacing and 96% for dipyridamole. In 60 patients successfully undergoing both alternative stress procedures, sensitivity and specificity were 83% and 76% for atrial pacing and 43% and 92% for dipyridamole echocardiography, respectively. In the group of 24 patients with nondiagnostic exercise echocardiography and consequent indication to alternative stress procedures, accuracy of transesophageal atrial pacing was higher than that of dipyridamole echocardiography (73% vs. 45%, p = 0.06).
CONCLUSIONS: Because of its higher diagnostic potential and additional functional information, exercise is the stress of choice when stress echocardiography is used to detect the presence of coronary artery disease. Alternative stresses can be used in patients with nondiagnostic exercise echocardiography. Transesophageal and dipyridamole echocardiography differ in feasibility and diagnostic reliability (higher sensitivity of transesophageal atrial pacing, higher specificity of dipyridamole). These characteristics must be considered when selecting procedures to be used as alternatives to exercise.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006254     DOI: 10.1016/0735-1097(94)90551-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Anatomy of a meta-analysis: a critical review of "exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance".

Authors:  S M Kymes; D E Bruns; L J Shaw; K N Gillespie; J W Fletcher
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  A meta-analytic comparison of echocardiographic stressors.

Authors:  Yoshinori Noguchi; Shizuko Nagata-Kobayashi; James E Stahl; John B Wong
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

3.  Efficacy of post exercise pulsed wave tissue velocity imaging in diagnosing more than 70% coronary artery stenosis.

Authors:  S R Mittal
Journal:  Indian Heart J       Date:  2012-12-26

4.  A novel catecholamine, arbutamine, for a pharmacological cardiac stress agent.

Authors:  R Nagarajan; G Abou-Mohamed; T Myers; R W Caldwell
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

Review 5.  Pacing stress echocardiography.

Authors:  Suzana Gligorova; Marco Agrusta
Journal:  Cardiovasc Ultrasound       Date:  2005-12-09       Impact factor: 2.062

6.  Pharmacological and simulated exercise cardiac stress tests produce different ischemic signatures in high-resolution experimental mapping studies.

Authors:  Brian Zenger; Wilson W Good; Jake A Bergquist; Lindsay C Rupp; Maura Perez; Gregory J Stoddard; Vikas Sharma; Rob S MacLeod
Journal:  J Electrocardiol       Date:  2021-07-24       Impact factor: 1.380

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.